Related Experiment Video
Updated: Dec 11, 2025

03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.7K
STEMI and COVID-19 Pandemic in Saudi Arabia
Current Problems in Cardiology
|August 26, 2020
Summary
The COVID-19 pandemic reduced ST-segment elevation myocardial infarction (STEMI) volumes and increased symptom-to-treatment times, despite maintaining care standards. Patient presentation delays were observed during the pandemic.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- The COVID-19 pandemic significantly impacted global healthcare, leading to reduced elective admissions and increased virtual care.
- Understanding the pandemic's effect on acute cardiovascular events like ST-segment elevation myocardial infarction (STEMI) is crucial.
Purpose of the Study:
- To assess changes in STEMI volumes, door-to-reperfusion times, and in-hospital events before and during the COVID-19 pandemic.
- To compare STEMI patient care metrics between the pre-COVID-19 (PC) and acute COVID-19 (AC) periods.
Main Methods:
- Retrospective analysis of 1,785 acute STEMI cases across 16 centers in Saudi Arabia.
- Data collected from January 1 to April 30, 2020 (COVID-19 period) and compared to January 1 to April 30, 2018-2019 (pre-COVID period).
Main Results:
- Total STEMI volumes decreased by 28% (n=500) and reperfusion-treated STEMI volumes by 27.6% (n=450) during the pandemic.
- Door-to-balloon time <90 minutes was achieved in 73.1% of cases in 2020.
- The proportion of patients experiencing symptom onset to reperfusion times >12 hours significantly increased to 17.2% in 2020 compared to <3% pre-COVID.
- No significant differences were found in in-hospital events or length of hospital stay between the periods.
Conclusions:
- STEMI volumes decreased during the COVID-19 pandemic, with a notable increase in delayed patient presentation.
- The standard of care for STEMI patients was maintained, but delays in seeking medical attention were evident.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
475
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
475
Pulmonary Embolism I: Introduction
364
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
364
Pulmonary Embolism III: Nursing Management
192
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
192
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
151
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
151
Coronary Artery Disease IV: Preventive Measures
509
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
509
Acute Respiratory Failure-II
856
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
856

